Pulmonary infection in the compromised host: part I.
D000908:Antibodies, Fungal / Q000032:analysis; D001228:Aspergillosis / Q000188:drug therapy / Q000276:immunology; D002177:Candidiasis / Q000276:immunology / Q000473:pathology; D003453:Cryptococcosis / Q000188:drug therapy / Q000276:immunology / Q000473:pathology; D005658:Fungi / Q000472:pathogenicity; D006801:Humans; D007111:Immunity, Cellular; D007153:Immunologic Deficiency Syndromes / Q000150:complications*; D007165:Immunosuppression Therapy / Q000009:adverse effects; D008168:Lung / Q000473:pathology; D008171:Lung Diseases / Q000276:immunology*; D008172:Lung Diseases, Fungal / Q000276:immunology; D009369:Neoplasms / Q000150:complications; D009617:Nocardia Infections / Q000276:immunology; D010587:Phagocytosis
D000908:Antibodies, Fungal